Severity
Critical
FDA Devices recall · Reported March 9, 2022
The affected lot was placed under quarantine in September 2021 due to complaints of alleged false positives, but 243 kits were erroneously released to customers in December 2021.
Celltrion USA INC recalled Celltrion DiaTrust COVID-19 Ag Rapid Test, Reference No. CT-P60 D-2 02 - a critical-severity action.
Celltrion DiaTrust COVID-19 Ag Rapid Test, Reference No. CT-P60 D-2 02 was recalled by Celltrion USA INC in March 9, 2022. Reason: The affected lot was placed under quarantine in September 2021 due to complaints of alleged false positives, …. Check the official notice for the remedy. Verify recall #Z-0659-2022 with the FDA Devices before acting.
The recall
Celltrion USA INC issued this critical-severity FDA Devices recall-The affected lot was placed under quarantine in September 2021 due to complaints of alleged false positives, ….
Sourced from official FDA Devices enforcement records. Verify recall #Z-0659-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-0659-2022) was formally reported on March 9, 2022, with the manufacturer initiating the action on December 28, 2021. It is classified under Critical severity (Class I), with a current status of Terminated. Celltrion USA INC is listed as the recalling firm, operating out of Jersey City, NJ. Federal records list the affected scope as 243 kits (6,075 tests).
The documented reason for this recall is: The affected lot was placed under quarantine in September 2021 due to complaints of alleged false positives, but 243 kits were erroneously released to customers in December 2021. Distribution data in the federal record shows the product reached: US distribution to CA, FL, NJ, NY, PA, SC.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
243 kits (6,075 tests)
Related Recalls
6
3 from same agency
Celltrion DiaTrust COVID-19 Ag Rapid Test, Reference No. CT-P60 D-2 02
The affected lot was placed under quarantine in September 2021 due to complaints of alleged false positives, but 243 kits were erroneously released to customers in December 2021.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | Z-0659-2022 |
| Date reported | March 9, 2022 |
| Date initiated | December 28, 2021 |
| Recalling firm | Celltrion USA INC |
| Firm location | Jersey City, NJ |
| Affected scope | 243 kits (6,075 tests) |
| Distribution | US distribution to CA, FL, NJ, NY, PA, SC. |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported March 9, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.